Wensheng Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wensheng Hu has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Sha Lu
Department of Women's health, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
10 shared publications- Sha Lu
Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, People’s Republic of China
5 shared publications - Yuanqing Fu
Research Center for Industries of the Future, School of Medicine, School of Life Sciences, Westlake University, Hangzhou, China
4 shared publications Zelei Miao
Affiliated Hangzhou First People's Hospital, School of Medicine
4 shared publicationsCongmei Xiao
Affiliated Hangzhou First People's Hospital, School of Medicine
3 shared publications- Ju-Sheng Zheng
Research Center for Industries of the Future, School of Medicine, School of Life Sciences, Westlake University, Hangzhou, China
3 shared publications
Latest Publications
- 15 October 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-5
Metabolomic analysis elucidates purine and amino acid as major toxicological biomarkers of triptolide in zebrafish
1. Triptolide, a diterpenoid from Tripterygium wilfordii, shows potent anti-inflammatory and immunosuppressive activities but is limited by severe organ toxicities including hepatotoxicity, nephrot...
- 15 October 2026
- Published by Taylor & Francis in Natural Product Research
- p. 1-5
Metabolomic analysis elucidates purine and amino acid as major toxicological biomarkers of triptolide in zebrafish
1. Triptolide, a diterpenoid from Tripterygium wilfordii, shows potent anti-inflammatory and immunosuppressive activities but is limited by severe organ toxicities including hepatotoxicity, nephrot...
- Open Access
- 23 April 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2661417
Gut microbiome and pregnancy complications: emerging evidence and mechanistic insights
The gut microbiome undergoes significant alterations during pregnancy. Perturbations in these microbial communities are increasingly associated with a range of pregnancy complications, including miscarriage, gestational diabetes mellitus, preeclampsia, preterm birth, and fetal growth restriction, among others. This review synthesizes current evidence on the dynamic changes in the maternal gut microecosystem including bacterial, fungal, and viral communities throughout gestation and examines its relationships with various pregnancy complications. We also summarize the underlying mechanisms driving these interactions, focusing on metabolic regulations involving short-chain fatty acids, bile acids, indoles, sex hormones, intestinal barrier integrity, and the modulation of maternal immune responses essential for fetal tolerance. Additionally, we discuss the lasting impact of the maternal microbiome on offspring health via vertical transmission and developmental programming. This review provides a conceptual framework that integrates mechanistic insights with clinical findings, with the goal of informing future research and supporting the development of microbiome-based interventions to improve maternal and neonatal health outcomes.
- 23 April 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2661417
Open AccessGut microbiome and pregnancy complications: emerging evidence and mechanistic insights
The gut microbiome undergoes significant alterations during pregnancy. Perturbations in these microbial communities are increasingly associated with a range of pregnancy complications, including miscarriage, gestational diabetes mellitus, preeclampsia, preterm birth, and fetal growth restriction, among others. This review synthesizes current evidence on the dynamic changes in the maternal gut microecosystem including bacterial, fungal, and viral communities throughout gestation and examines its relationships with various pregnancy complications. We also summarize the underlying mechanisms driving these interactions, focusing on metabolic regulations involving short-chain fatty acids, bile acids, indoles, sex hormones, intestinal barrier integrity, and the modulation of maternal immune responses essential for fetal tolerance. Additionally, we discuss the lasting impact of the maternal microbiome on offspring health via vertical transmission and developmental programming. This review provides a conceptual framework that integrates mechanistic insights with clinical findings, with the goal of informing future research and supporting the development of microbiome-based interventions to improve maternal and neonatal health outcomes.
- Open Access
- 5 February 2026
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 23 (1)
Association of plant-based diet with the risk of large-for-gestational-age birth in women with gestational diabetes mellitus
The distribution of dietary macronutrients is critical for blood glucose management and adverse birth outcomes among pregnant women with gestational diabet
- 5 February 2026
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 23 (1)
Open AccessAssociation of plant-based diet with the risk of large-for-gestational-age birth in women with gestational diabetes mellitus
The distribution of dietary macronutrients is critical for blood glucose management and adverse birth outcomes among pregnant women with gestational diabet
- 1 February 2026
- Vol. 35 (1) , 158-163
Association between dietary protein intake and preterm birth in pregnant women with gestational diabetes mellitus: the WeBirth cohort study.
The distribution of dietary macronutrients is essential for blood glucose management in patients with gestational diabetes mellitus (GDM). However, the relationship between dietary protein intake and the risk of preterm birth remains unclear. Here, we aim to investigate the prospective association between dietary protein intake and preterm birth in patients with GDM. We included 1756 GDM patients and assessed dietary protein patterns by constructing total protein index (TPI), animal protein index (API), and plant protein index (PPI) using data collected from food frequency questionnaires (FFQ). We found that individuals in the highest quartile of TPI (OR: 2.75, 95% CI: 0.81 to 9.22) and API (OR: 3.64, 95% CI: 1.48 to 9.47) had a significantly higher risk of preterm birth compared to those in the lowest quartile. This study suggests that increasing protein intake, especially from animal sources, was associated with a greater risk of preterm birth in patients with GDM.
- 1 February 2026
- Vol. 35 (1) , 158-163
Association between dietary protein intake and preterm birth in pregnant women with gestational diabetes mellitus: the WeBirth cohort study.
The distribution of dietary macronutrients is essential for blood glucose management in patients with gestational diabetes mellitus (GDM). However, the relationship between dietary protein intake and the risk of preterm birth remains unclear. Here, we aim to investigate the prospective association between dietary protein intake and preterm birth in patients with GDM. We included 1756 GDM patients and assessed dietary protein patterns by constructing total protein index (TPI), animal protein index (API), and plant protein index (PPI) using data collected from food frequency questionnaires (FFQ). We found that individuals in the highest quartile of TPI (OR: 2.75, 95% CI: 0.81 to 9.22) and API (OR: 3.64, 95% CI: 1.48 to 9.47) had a significantly higher risk of preterm birth compared to those in the lowest quartile. This study suggests that increasing protein intake, especially from animal sources, was associated with a greater risk of preterm birth in patients with GDM.
- Open Access
- 30 January 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Intestinal fungal dysbiosis in gestational diabetes mellitus is associated with adverse pregnancy outcomes
Our study aims to compare the differences in gut fungal community structure between pregnant women with gestational diabetes mellitus (GDM) and healthy pre
- 30 January 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessIntestinal fungal dysbiosis in gestational diabetes mellitus is associated with adverse pregnancy outcomes
Our study aims to compare the differences in gut fungal community structure between pregnant women with gestational diabetes mellitus (GDM) and healthy pre
- Open Access
- 5 December 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1294
The predictive potential of the placental chorioangioma diameter for adverse pregnancy outcomes: a single-centre retrospective study
Placental chorioangioma (PCA) is a rare placental tumour that may significantly compromise pregnancy outcomes. However, the optimal diameter cutoff value f
- 5 December 2025
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 25 (1) , 1294
Open AccessThe predictive potential of the placental chorioangioma diameter for adverse pregnancy outcomes: a single-centre retrospective study
Placental chorioangioma (PCA) is a rare placental tumour that may significantly compromise pregnancy outcomes. However, the optimal diameter cutoff value f
- 15 July 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 207-215
Effect of weight gain rate in the second and third trimesters of pregnancy on maternal and neonatal health: A cross-sectional study
- 15 July 2025
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 69, 207-215
Effect of weight gain rate in the second and third trimesters of pregnancy on maternal and neonatal health: A cross-sectional study
- 15 January 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (7) , 1107-1116
Horizontal and longitudinal targeted metabolomics in healthy pregnancy and gestational diabetes mellitus
Objective The objective is to investigate the differences in urinary organic acid (OA) profiles and metabolism between healthy control (HC) pregnant women and those with gestational diabetes mellitus (GDM) during the second trimester and third trimester of pregnancy. Methods A total of 66 HC pregnant women and 32 pregnant women with GDM were assessed for 107 hydrophilic metabolites in urine samples collected during the second and third trimester of pregnancy using tandem mass spectrometry. The urine OA profiles for each group were obtained, and metabolomic analysis and discussion were conducted. Results This study identified a total of 50 metabolic biomarkers. In the third trimester of pregnancy, short-chain dicarboxylic acids (DCAs) and tryptophan (Trp)-related metabolites were significantly upregulated in the urine of both the HC group and the GDM group. Comparatively, the glycine (Gly) levels and related synthetic precursor metabolites were lower in the GDM2 group. The overall dietary polyphenol metabolic intermediates level in the GDM group was lower than in the HC group. Among the pathways enriched for differentially expressed metabolites, the predominant metabolic pathway in the GDM group was the citric acid cycle. In contrast, in the HC group, it was the metabolism of alanine, aspartate, and glutamate. Conclusions The study reveals the differences in metabolomics between pregnant women with HC and those with GDM, identifying several metabolites associated with the occurrence and development of GDM. Demonstrating the presence of abnormal mitochondrial and peroxisomal functions at the metabolite level in GDM will contribute to future exploration of the condition.
- 15 January 2025
- Published by Springer Nature in Acta Diabetologica
- Vol. 62 (7) , 1107-1116
Horizontal and longitudinal targeted metabolomics in healthy pregnancy and gestational diabetes mellitus
Objective The objective is to investigate the differences in urinary organic acid (OA) profiles and metabolism between healthy control (HC) pregnant women and those with gestational diabetes mellitus (GDM) during the second trimester and third trimester of pregnancy. Methods A total of 66 HC pregnant women and 32 pregnant women with GDM were assessed for 107 hydrophilic metabolites in urine samples collected during the second and third trimester of pregnancy using tandem mass spectrometry. The urine OA profiles for each group were obtained, and metabolomic analysis and discussion were conducted. Results This study identified a total of 50 metabolic biomarkers. In the third trimester of pregnancy, short-chain dicarboxylic acids (DCAs) and tryptophan (Trp)-related metabolites were significantly upregulated in the urine of both the HC group and the GDM group. Comparatively, the glycine (Gly) levels and related synthetic precursor metabolites were lower in the GDM2 group. The overall dietary polyphenol metabolic intermediates level in the GDM group was lower than in the HC group. Among the pathways enriched for differentially expressed metabolites, the predominant metabolic pathway in the GDM group was the citric acid cycle. In contrast, in the HC group, it was the metabolism of alanine, aspartate, and glutamate. Conclusions The study reveals the differences in metabolomics between pregnant women with HC and those with GDM, identifying several metabolites associated with the occurrence and development of GDM. Demonstrating the presence of abnormal mitochondrial and peroxisomal functions at the metabolite level in GDM will contribute to future exploration of the condition.
- Open Access
- 7 October 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (10) , e70115
Identification of key ubiquitination‐related genes in gestational diabetes mellitus: A bioinformatics‐driven study
Background and Aims: Gestational diabetes mellitus (GDM) is characterized by glucose intolerance that occurs during pregnancy. This study aimed to identify key ubiquitination‐related genes associated with GDM pathogenesis.Methods: Microarray data from GSE154377 was analyzed to identify differentially expressed genes (DEGs) in GDM vs normal pregnancy samples. Weighted gene co‐expression network analysis was performed on ubiquitination‐related genes. Functional enrichment, protein‐protein interaction network, and TF‐mRNA‐miRNA interaction network analyses were conducted on differentially expressed ubiquitination‐related genes (DE‐URGs).Results: We identified 2337 DEGs and 65 DE‐URGs in GDM. Functional enrichment analysis of the 65 DE‐URGs revealed involvement in protein ubiquitination and ubiquitin‐dependent catabolic processes. Protein‐protein interaction network analysis identified 8 hub genes, including MAP1LC3C, USP26, USP6, UBE2U, USP2, USP43, UCHL1, and USP44. ROC curve analysis showed these hub genes have high diagnostic accuracy for GDM (AUC > 0.6). The TF‐mRNA‐miRNA interaction network suggested USP2 and UCHL1 may be key ubiquitination genes in GDM.Conclusion: In conclusion, this study contributes to our understanding of the molecular landscape of GDM by uncovering key ubiquitination‐related genes. These findings may serve as a foundation for further investigations, offering potential biomarkers and therapeutic targets for clinical applications in GDM management.
- 7 October 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (10) , e70115
Open AccessIdentification of key ubiquitination‐related genes in gestational diabetes mellitus: A bioinformatics‐driven study
Background and Aims: Gestational diabetes mellitus (GDM) is characterized by glucose intolerance that occurs during pregnancy. This study aimed to identify key ubiquitination‐related genes associated with GDM pathogenesis.Methods: Microarray data from GSE154377 was analyzed to identify differentially expressed genes (DEGs) in GDM vs normal pregnancy samples. Weighted gene co‐expression network analysis was performed on ubiquitination‐related genes. Functional enrichment, protein‐protein interaction network, and TF‐mRNA‐miRNA interaction network analyses were conducted on differentially expressed ubiquitination‐related genes (DE‐URGs).Results: We identified 2337 DEGs and 65 DE‐URGs in GDM. Functional enrichment analysis of the 65 DE‐URGs revealed involvement in protein ubiquitination and ubiquitin‐dependent catabolic processes. Protein‐protein interaction network analysis identified 8 hub genes, including MAP1LC3C, USP26, USP6, UBE2U, USP2, USP43, UCHL1, and USP44. ROC curve analysis showed these hub genes have high diagnostic accuracy for GDM (AUC > 0.6). The TF‐mRNA‐miRNA interaction network suggested USP2 and UCHL1 may be key ubiquitination genes in GDM.Conclusion: In conclusion, this study contributes to our understanding of the molecular landscape of GDM by uncovering key ubiquitination‐related genes. These findings may serve as a foundation for further investigations, offering potential biomarkers and therapeutic targets for clinical applications in GDM management.